13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q2 2021. See the latest, Q3 2026 →
Reported value
$12.33B
−1.9% on the quarter before
Positions
59
8 new, 8 sold out
Top 10
68.0%
of the value
Est. gain
+$514.0M
on stocks held all quarter
Est. return
+4.7%
on those stocks since Q1 2021
Positions as of Jun 30, 2021, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.
Largest buys
Since Q1 2021, sized at quarter-end prices.
- Shaw Communications Inc~$218.1MNew, 0.0% → 1.8% of the portfolio+7,530,807 shares
- Digitalbridge Group Inc~$180.7MNew, 0.0% → 1.5% of the portfolio+22,877,059 shares
- Micron~$147.9MAdded, 3.8% → 4.9% of the portfolio+1,740,000 shares
- Meta~$86.9MAdded, 3.0% → 4.4% of the portfolio+250,000 shares
- Ironsource Ltd~$80.1MNew, 0.0% → 0.6% of the portfolio+8,000,000 shares
- Reinvent Technology Partners~$59.3MNew, 0.0% → 0.5% of the portfolio+6,000,000 shares
- Garrett Motion Inc~$28.5MNew, 0.0% → 0.2% of the portfolio+3,575,000 shares
- Qorvo~$21.5MAdded, 7.6% → 8.5% of the portfolio+110,000 shares
- Theravance Biopharma Inc~$17.1MAdded, 1.4% → 1.2% of the portfolio+1,175,000 shares
- The Beauty Health Company~$5.8MNew, 0.0% → 0.0% of the portfolio+898,981 shares
Largest sells
Since Q1 2021, sized at quarter-end prices.
- Fox Corp~$274.8MSold out, 2.2% → 0.0% of the portfolio−7,610,818 shares
- Ebay Inc.~$241.1MCut, 8.9% → 8.5% of the portfolio−3,433,800 shares
- Fox Corp~$198.4MSold out, 1.6% → 0.0% of the portfolio−5,680,307 shares
- Healthpeak Properties Inc~$157.7MSold out, 1.3% → 0.0% of the portfolio−4,966,911 shares
- Colony Cap Inc New~$156.9MSold out, 1.2% → 0.0% of the portfolio−24,212,959 shares
- Willis Towers Watson Plc Ltd~$140.0MCut, 4.6% → 3.5% of the portfolio−608,474 shares
- Fidelity National Financial~$123.5MSold out, 1.0% → 0.0% of the portfolio−3,036,935 shares
- Intel~$87.6MCut, 11.9% → 9.9% of the portfolio−1,560,384 shares
- Reinvent Technology Partners~$60.2MSold out, 0.5% → 0.0% of the portfolio−6,000,000 shares
- Pershing Square Tontine Hldg~$59.6MCut, 2.4% → 1.9% of the portfolio−2,617,269 shares
Holdings
As of Jun 30, 2021; changes in shares since Mar 31, 2021.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liberty Global PlcSHS CL C · shares −1.1% · price +5.9% | 11.8% | $1.46B | +$81.0M | ||||||
| IntelCOM · shares −6.7% · price −12.3% | 9.9% | $1.22B | −$170.9M | ||||||
| Ebay Inc.COM · shares −19% · price +14.6% | 8.5% | $1.05B | +$133.6M | ||||||
| QorvoCOM · shares +2.1% · price +7.1% | 8.5% | $1.04B | +$67.7M | ||||||
| Viasat IncCOM · shares 0% · price +3.7% | 6.6% | $811.8M | +$28.8M | ||||||
| AlphabetCAP STK CL C · shares 0% · price +21.2% | 5.9% | $729.2M | +$127.3M | ||||||
| MicronCOM · shares +32% · price −3.7% | 4.9% | $608.7M | −$17.5M | ||||||
| MetaCL A · shares +19% · price +18.1% | 4.4% | $537.9M | +$69.0M | ||||||
| Translate Bio IncCOM · shares 0% · price +66.8% | 4.0% | $493.5M | +$197.7M | ||||||
| Willis Towers Watson Plc LtdSHS · shares −24% · price +0.5% | 3.5% | $435.1M | +$2.2M | ||||||
| International Flavors&FragraCOM · shares 0% · price +7.0% | 2.5% | $313.7M | +$20.6M | ||||||
| Pg&E CorpCOM · shares 0% · price −13.2% | 2.5% | $311.8M | −$47.2M | ||||||
| Nexstar Media Group IncCL A · shares −1.9% · price +5.3% | 2.5% | $302.6M | +$15.2M | ||||||
| Liberty Media Corp DelCOM C SIRIUSXM · shares 0% · price +5.2% | 2.4% | $300.8M | +$14.8M | ||||||
| Ss&C Technologies Hldgs IncCOM · shares −13% · price +3.1% | 1.9% | $239.0M | +$7.3M | ||||||
| Pershing Square Tontine HldgCOM CL A · shares −21% · price −5.2% | 1.9% | $229.7M | −$12.6M | ||||||
| Veritiv CorpCOM · shares 0% · price +44.4% | 1.8% | $218.9M | +$67.3M | ||||||
| Shaw Communications IncCL B CONV · shares New | 1.8% | $218.1M | — | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price +5.8% | 1.7% | $208.0M | +$11.5M | ||||||
| Digitalbridge Group IncCL A COM · shares New | 1.5% | $180.7M | — | ||||||
| Liberty Media Corp DelCOM A SIRIUSXM · shares 0% · price +5.7% | 1.3% | $163.0M | +$8.8M | ||||||
| Theravance Biopharma IncCOM · shares +13% · price −28.9% | 1.2% | $143.9M | −$51.5M | ||||||
| Verint Sys IncCOM · shares 0% · price −0.9% | 1.1% | $137.0M | −$1.3M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price +8.3% | 1.1% | $131.8M | +$10.1M | ||||||
| Advantage Solutions IncCOM CL A · shares −2.4% · price −7.5% | 1.1% | $129.6M | −$10.5M | ||||||
| Total 59 positions | 100% | $12.33B | +$514.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2021 to Q2 2021: 50 stocks held throughout, up $514.0M (+4.7%).
- Translate Bio Inc+$197.7M+67%
- Ebay Inc.+$133.6M+15%
- Alphabet+$127.3M+21%
- Liberty Global Plc+$81.0M+6%
- Meta+$69.0M+18%
- Micron−$17.5M−4%
- Cullinan Oncology Inc−$25.4M−35%
- Pg&E Corp−$47.2M−13%
- Theravance Biopharma Inc−$51.5M−29%
- Intel−$170.9M−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |